Aycan and Enspectra partner for clinical trials on cellular imaging system

Radiology workflow and data management company Aycan Medical Systems has expanded into the clinical trials market. 

In a partnership with medical imaging diagnostics company Enspectra Health, Aycan provided imaging data management to support a pivotal clinical trial of Enspectra’s new VIO system. The first-of-its-kind technology visualizes, captures and stores images at the cellular level for more clinically accurate assessments of health. For now, VIO has received FDA clearance for use on skin after the successful proof-of-concept study.

According to a statement, the partnership between the two companies will be ongoing, with Enspectra utilizing Aycan cloud PACS and DICOM image archiving as it looks to conduct more trials to expand applications for VIO. 

Enspectra’s website states its cellular imaging capabilities will have a variety of clinical applications.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.